Skip to main content
Advertisement
Advertisement

COCH

COCH logo

Envoy Medical, Inc. Class A Common Stock

0.73
USD
Sponsored
-0.01
-1.36%
Sep 14, 15:18 UTC -4
Closed
exchange

After-Market

0.73

0.00
-0.01%

COCH Earnings Reports

Positive Surprise Ratio

COCH beat 3 of 10 last estimates.

30%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$30.60K
/
-$0.07
Implied change from Q2 26 (Revenue/ EPS)
-40.00%
/
--
Implied change from Q3 25 (Revenue/ EPS)
-27.14%
/
-79.41%

Envoy Medical, Inc. Class A Common Stock earnings per share and revenue

On Aug 10, 2026, COCH reported earnings of -0.07 USD per share (EPS) for Q2 26, beating the estimate of -0.08 USD, resulting in a 14.22% surprise. Revenue reached 51.00 thousand, compared to an expected 81.60 thousand, with a -37.50% difference. The market reacted with a +5.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 30.60 thousand USD, implying an increase of 0.00% EPS, and decrease of -40.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.80
Surprise
-380.19%
FAQ
For Q2 2026, Envoy Medical, Inc. Class A Common Stock reported EPS of -$0.07, beating estimates by 14.22%, and revenue of $51.00K, -37.5% below expectations.
The stock price moved up 5.04%, changed from $0.67 before the earnings release to $0.70 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 3 analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.07 and revenue of $30.60K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement